BioCentury
ARTICLE | Company News

Alvos, Arrowhead deal

April 16, 2012 7:00 AM UTC

Arrowhead acquired Alvos (formerly Mercator Therapeutics Inc.) for 315,467 shares of Arrowhead restricted common stock valued at about $2 million, based on Arrowhead's close of $6.35 on April 10, bef...